Due to health issues, this site is no longer maintained and will be shut down shortly.


Silo Pharma Inc. operates as an early stage biopharmaceutical company. It focuses on the use of psychedelic therapeutics for patients suffering from various indications, such as depression, PTSD, Alzheimer's, and other rare neurological disorders. The company was formerly known as Uppercut Brands Inc. and changed its name to Silo Pharma Inc. in September 2020. Silo Pharma Inc. was incorporated in 2010 and is based in Teaneck, New Jersey.

As of 12/09/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Index country:  USA
Country of incorporation:  
IPO date:  12/24/2020
Outstanding shares:  3,138,797
Average volume:  189,666
Market cap:   $6,403,146
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy